Catalent stops production at French plant, brings in law enforcement after it twice detects tampering - FiercePharma

Read the full article: Catalent stops production at French plant, brings in law enforcement after it twice detects tampering - FiercePharma:

"U.S.-based Catalent ($CTLT) has halted production at a softgel capsule manufacturing facility in France at the request of regulators after several incidents in which it appears someone within the plant purposely mixed the wrong capsules into batches. The company said it is working with French law enforcement and regulators to find out what happened."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 

GlaxoSmithKline flags product tampering as wrong pills surface in alli packages - FiercePharma

• Trusted FDA cGMP online training programs and courses offered by SkillsPlus International Inc.

GlaxoSmithKline flags product tampering as wrong pills surface in alli packages - FiercePharma:

"The tampered-with packages have cropped up in 7 states, GSK said, and sharp-eyed consumers have reported 5 different lot numbers. The rogue packages may appear to be authentic on the outside, but the bottle could contain a variety of tablets and capsules, the company said in a release.

Also, the suspect alli bottles may not be labeled, and tamper-evident seals may not be intact, or they may not match the official versions. Finally, lot numbers and expiration dates on the bottles and outer cartons don't match."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog